Long-Term Fluoxetine Treatment of Bulimia Nervosa
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background: A large collaborative 8-week study has shown fluoxetine to be effective and safe in treating patients with bulimia nervosa. The present study evaluated fluoxetine over 16 weeks. Method: Fifteen US out-patient psychiatry clinics conducted a double-blind parallel study in men and women with DSM–III–R bulimia nervosa (483 patients entered, 398 randomised [3:1 ratio, fluoxetine 60 mg/day or placebo], 225 completed). Outcome measures included change in vomiting and binge-eating episodes per week, Eating Disorder Inventory, Clinical Global Impressions and Patient's Global Impression. Results: Compared with placebo, fluoxetine treatment resulted in significantly greater reductions in vomiting (F [1,360] = 14.73, P< 0.0001) and binge-eating (F [1,360] = 14.39, P=0.0002) episodes per week at endpoint and improvement in other outcome measures. Adverse event, vital sign and laboratory analyses indicated that fluoxetine was safe. Conclusion: Fluoxetine appeared to be safe and effective in patients with bulimia nervosa for up to 16 weeks.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
Statistical Power Analysis for the Behavioral Sciences
(1977) · doi:10.1016/c2013-0-10517-x · Cited by 2,457
(1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820020059008 · Cited by 371
Cited by
Bulimia nervosa treatment: A systematic review of randomized controlled trials
Shapiro, J. R., Berkman, N. D., Brownley, K. A., Sedway, J. A., Lohr, K. N., & Bulik, C. M. (2007) · International Journal of Eating Disorders · doi:10.1002/eat.20372 · Cited by 630
Aigner, M., Treasure, J., Kaye, W., Kasper, S., & The WFSBP Task Force on Eating Disorders (2011) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.602720 · Cited by 207
“Goldstein et al. (1995) reported a multicenter (15 outpatient clinics) double blind placebo controlled study with fl uoxetine in 398 patients with bulimia nervosa.”
BackgroundPsychotherapy for bulimia nervosa and binging
Hay, P. P., Bacaltchuk, J., & Stefano, S. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000562.pub2 · Cited by 175
Goldstein, B. J., & Goodnick, P. J. (1998) · Journal of Psychopharmacology · doi:10.1177/0269881198012003041 · Cited by 171
Bulimia nervosa: A meta-analysis of psychosocial and pharmacological treatments
Whittal, M. L., Agras, W. S., & Gould, R. A. (1999) · Behavior Therapy · doi:10.1016/s0005-7894(99)80049-5 · Cited by 159
Metadata
- Authors
- Goldstein, D. J., Wilson, M. G., Thompson, V. L., Potvin, J. H., Rampey, A. H., & The Fluoxetine Bulimia Nervosa Research Group
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 1995-05
- Volume
- 166
- Issue
- 5
- Pages
- 660-666
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2148690325
- Cited by
- 215
- References
- 3
- FWCI
- 9.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Long-Term Fluoxetine Treatment of Bulimia Nervosa. https://app.cochat.ai/papers/10.1192/bjp.166.5.660
- The paper
- Goldstein, D. J., Wilson, M. G., Thompson, V. L., Potvin, J. H., Rampey, A. H., & The Fluoxetine Bulimia Nervosa Research Group. (1995). Long-Term Fluoxetine Treatment of Bulimia Nervosa. British Journal of Psychiatry. https://doi.org/10.1192/bjp.166.5.660
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.